People with the heritable disorder of the skin called Gorlin syndrome who are genetically predisposed to develop basal cell carcinoma of the skin may have a new chemoprevention therapy on the horizon.
Celebrex inhibits burden of skin cancer in high-risk patients, research finds
January 10th, 2010 by Newspublichealth.com
Leave a Reply
Sorry, no posts matched your criteria.